Comerica Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$34.4M Sell
637,744
-25,379
-4% -$1.22M 0.14% 133
2025
Q3
$29.9M Buy
663,123
+2,196
+0.3% +$103K 0.11% 166
2025
Q2
$30.6M Sell
660,927
-12,612
-2% -$619K 0.12% 156
2025
Q1
$41.1M Sell
673,539
-34,094
-5% -$1.99M 0.17% 110
2024
Q4
$40M Sell
707,633
-14,604
-2% -$816K 0.16% 118
2024
Q3
$37.4M Buy
722,237
+35,152
+5% +$1.65M 0.15% 131
2024
Q2
$28.5M Sell
687,085
-33,220
-5% -$1.49M 0.12% 150
2024
Q1
$39.1M Buy
720,305
+25,716
+4% +$1.31M 0.17% 110
2023
Q4
$35.6M Sell
694,589
-54,233
-7% -$2.85M 0.16% 117
2023
Q3
$43.5M Buy
748,822
+367,044
+96% +$22.5M 0.23% 84
2023
Q2
$99 Buy
+381,778
New +$25.6M 0.01% 106
2022
Q4
$37.5M Buy
518,857
+2,323
+0.4% +$175K 0.29% 55
2022
Q3
$37.7M Buy
516,534
+5,213
+1% +$378K 0.32% 49
2022
Q2
$37.4M Sell
511,321
-16,735
-3% -$1.27M 0.31% 49
2022
Q1
$40.8M Buy
528,056
+4,525
+0.9% +$304K 0.3% 52
2021
Q4
$32.7M Buy
523,531
+8,991
+2% +$527K 0.24% 64
2021
Q3
$29.6M Sell
514,540
-74,279
-13% -$4.89M 0.18% 95
2021
Q2
$40.3M Sell
588,819
-40,142
-6% -$2.62M 0.24% 68
2021
Q1
$41.5M Sell
628,961
-27,709
-4% -$1.72M 0.25% 60
2020
Q4
$42.4M Sell
656,670
-27,106
-4% -$1.67M 0.27% 58
2020
Q3
$41.1M Buy
683,776
+9,007
+1% +$542K 0.3% 59
2020
Q2
$40.4M Buy
674,769
+38,955
+6% +$2.33M 0.31% 57
2020
Q1
$39.6M Sell
635,814
-14,732
-2% -$900K 0.36% 46
2019
Q4
$41.5M Buy
650,546
+127,843
+24% +$7.32M 0.31% 51
2019
Q3
$28.4M Buy
522,703
+3,360
+0.6% +$158K 0.22% 82
2019
Q2
$22.9M Sell
519,343
-816
-0.2% -$38K 0.18% 97
2019
Q1
$23.9M Buy
520,159
+10,169
+2% +$507K 0.19% 91
2018
Q4
$24.6M Sell
509,990
-3,236
-0.6% -$174K 0.21% 85
2018
Q3
$26M Sell
513,226
-85,565
-14% -$5.08M 0.21% 85
2018
Q2
$33.9M Sell
598,791
-7,173
-1% -$387K 0.24% 70
2018
Q1
$31.3M Sell
605,964
-10,367
-2% -$667K 0.22% 72
2017
Q4
$39.3M Sell
616,331
-3,088
-0.5% -$193K 0.26% 62
2017
Q3
$37.7M Sell
619,419
-5,127
-0.8% -$299K 0.27% 60
2017
Q2
$34.7M Sell
624,546
-8,681
-1% -$472K 0.26% 63
2017
Q1
$35.3M Sell
633,227
-7,897
-1% -$433K 0.27% 59
2016
Q4
$36M Sell
641,124
-6,909
-1% -$378K 0.29% 52
2016
Q3
$35.7M Sell
648,033
-52,997
-8% -$3.4M 0.31% 52
2016
Q2
$43.2M Sell
701,030
-17,142
-2% -$1.21M 0.37% 41
2016
Q1
$48.9M Buy
718,172
+4,173
+0.6% +$263K 0.44% 36
2015
Q4
$45.4M Sell
713,999
-10,624
-1% -$702K 0.45% 35
2015
Q3
$42.9M Sell
724,623
-745,485
-51% -$47.3M 0.41% 38
2015
Q2
$97.8M Buy
1,470,108
+724,802
+97% +$47.8M 0.42% 37
2015
Q1
$48.1M Sell
745,306
-735,114
-50% -$46M 0.41% 38
2014
Q4
$87.4M Buy
1,480,420
+749,010
+102% +$42.2M 0.38% 45
2014
Q3
$37.4M Sell
731,410
-40,374
-5% -$2.02M 0.33% 52
2014
Q2
$37.4M Sell
771,784
-142,729
-16% -$7.03M 0.32% 53
2014
Q1
$47.5M Sell
914,513
-588
-0.1% -$31.3K 0.36% 45
2013
Q4
$48.6M Sell
915,101
-287,500
-24% -$14.6M 0.38% 42
2013
Q3
$55.7M Sell
1,202,601
-49,834
-4% -$2.19M 0.39% 40
2013
Q2
$56M Buy
+1,252,435
New +$54.4M 0.46% 35

Other funds holding BMY

Comerica Bank's BMY Position: Q4 2025 in Review

Comerica Bank reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q4 2025, selling an estimated $1.22M and leaving 637,744 shares worth $34.4M. The position accounts for 0.14% of the portfolio, ranked #133.

Comerica Bank first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $97.8M in Q2 2015. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Comerica Bank held 637,744 shares of Bristol-Myers Squibb worth $34.4M as of Q4 2025.
  • Comerica Bank sold 25,379 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.22M.
  • Bristol-Myers Squibb made up 0.14% of Comerica Bank's portfolio in Q4 2025, its #133 holding.
  • Comerica Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Bristol-Myers Squibb position peaked at $97.8M in Q2 2015.
  • 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.